Efficacy and safety of efgartigimod PH20 SC for Sjögren's disease-associated dryness: study protocol for an investigator-initiated, multicenter, phase 2, randomized, double-blind, placebo-controlled trial (OASIS study). - Endo Y; Hosogaya N; Fukushige Y; Narita S; Jacobs J; Reiss W; Imai Y; Shimizu T; Koga T; Yamamoto H; Sakai T; Takagi Y; et al. (Frontiers in medicine, 2026)